News
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the ...
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
By Stephanie Brown HealthDay ReporterWEDNESDAY, July 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center ...
The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...
George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine ...
2don MSN
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback